These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35936284)

  • 1. Understanding the Public Policy of Global Budget Payment Reform Improves the Quality of Public Healthcare From the Perspective of Patients in China.
    Li L; Zhang S
    Front Psychol; 2022; 13():911197. PubMed ID: 35936284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Forecasting the future reimbursement system of Korean National Health Insurance: a contemplation focusing on global budget and Neo-KDRG-based payment systems.
    Kim YK
    J Korean Med Sci; 2012 May; 27 Suppl(Suppl):S25-32. PubMed ID: 22661867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. China Promotes Sanming's Model: A National Template for Integrated Medicare Payment Methods.
    Zhong Z; Yao Q; Chen S; Jiang J; Lin K; Yao Y; Xiang L
    Int J Integr Care; 2023; 23(2):15. PubMed ID: 37188056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of global budget on cost control and readmission in rural China: a difference-in-difference analysis.
    He R; Miao Y; Ye T; Zhang Y; Tang W; Li Z; Zhang L
    J Med Econ; 2017 Sep; 20(9):903-910. PubMed ID: 28562140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impacts of health insurance benefit design on percutaneous coronary intervention use and inpatient costs among patients with acute myocardial infarction in Shanghai, China.
    Yuan S; Liu Y; Li N; Zhang Y; Zhang Z; Tao J; Shi L; Quan H; Lu M; Ma J
    Pharmacoeconomics; 2014 Mar; 32(3):265-75. PubMed ID: 23975740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impacts of Hospital Payment Based on Diagnosis Related Groups (DRGs) with Global Budget on Resource Use and Quality of Care: A Case Study in China.
    Yuan S; Liu W; Wei F; Zhang H; Wang S; Zhu W; Ma J
    Iran J Public Health; 2019 Feb; 48(2):238-246. PubMed ID: 31205877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How can Saudi Arabia reform its public hospital payment models? A narrative review.
    AlRuthia Y; Abdulaziz Bin Aydan N; Sulaiman Alorf N; Asiri Y
    Saudi Pharm J; 2020 Dec; 28(12):1520-1525. PubMed ID: 33041625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The challenge of healthcare big data to China's commercial health insurance industry: evaluation and recommendations.
    Wu J; Qiao J; Nicholas S; Liu Y; Maitland E
    BMC Health Serv Res; 2022 Sep; 22(1):1189. PubMed ID: 36138390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impacts of diagnosis-intervention packet payment on the providers' behavior of inpatient care-evidence from a national pilot city in China.
    Ding Y; Yin J; Zheng C; Dixon S; Sun Q
    Front Public Health; 2023; 11():1069131. PubMed ID: 37325323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addressing government and market failures with payment incentives: Hospital reimbursement reform in Hainan, China.
    Yip W; Eggleston K
    Soc Sci Med; 2004 Jan; 58(2):267-77. PubMed ID: 14604613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization and expenses of outpatient services among tuberculosis patients in three Chinese counties: an observational comparison study.
    Wang XX; Chen JY; Jiang H; Zhu AN; Long Q; Ji JS
    Infect Dis Poverty; 2019 Oct; 8(1):79. PubMed ID: 31581953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging lessons from regional and state innovation in value-based payment reform: balancing collaboration and disruptive innovation.
    Conrad DA; Grembowski D; Hernandez SE; Lau B; Marcus-Smith M
    Milbank Q; 2014 Sep; 92(3):568-623. PubMed ID: 25199900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospital response to a case-based payment scheme under regional global budget: The case of Guangzhou in China.
    Lai Y; Fu H; Li L; Yip W
    Soc Sci Med; 2022 Jan; 292():114601. PubMed ID: 34844079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does the separating of hospital revenue from drug sales reduce the burden on patients? Evidence from China.
    Li L; Yu Q
    Int J Equity Health; 2021 Jan; 20(1):12. PubMed ID: 33407503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling individual health care expenditures in China: Evidence to assist payment reform in public insurance.
    Shi J; Yao Y; Liu G
    Health Econ; 2018 Dec; 27(12):1945-1962. PubMed ID: 30044018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Payment methods for outpatient care facilities.
    Yuan B; He L; Meng Q; Jia L
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011153. PubMed ID: 28253540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmaceutical policies: effects of cap and co-payment on rational drug use.
    Austvoll-Dahlgren A; Aaserud M; Vist G; Ramsay C; Oxman AD; Sturm H; Kösters JP; Vernby A
    Cochrane Database Syst Rev; 2008 Jan; (1):CD007017. PubMed ID: 18254125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicare For All: An Analysis Of Key Policy Issues.
    Johnson M; Kishore S; Berwick DM
    Health Aff (Millwood); 2020 Jan; 39(1):133-141. PubMed ID: 31905054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in health expenditures in China in 2000s: has the health system reform improved affordability.
    Long Q; Xu L; Bekedam H; Tang S
    Int J Equity Health; 2013 Jun; 12():40. PubMed ID: 23764104
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.